BioNTech AG - Articles and news items

Study describes extraordinarily potent mRNA cancer immunotherapy

Industry news / 2 June 2016 / Victoria White, Digital Content Producer

BioNTech has announced the publication of a study that describes the first example of a clinically relevant and systemic mRNA cancer immunotherapy…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+